Literature DB >> 34661962

Tanshinone IIA inhibits gastric cancer cell stemness through inducing ferroptosis.

Haiwei Ni1, Guojing Ruan1, Cheng Sun2, Xuan Yang3, Zhenyan Miao1, Jifei Li1, Ying Chen1, Hai Qin1, Yichen Liu1, Lufeng Zheng1, Yingying Xing1, Tao Xi1, Xiaoman Li4.   

Abstract

Tanshinone IIA is the active constituent extracted from Salvia Miltiorrhza. Numerous studies have shown that Tanshinone IIA could inhibit tumor proliferation and metastasis, including gastric cancer. However, the effect of Tanshinone IIA on gastric cancer cell stemness stays unclear. Here, we found that Tanshinone IIA could reduce gastric cancer cell stemness through detecting spheroid-forming, flow cytometry analysis, and the expression of stemness markers (OCT3/4, ALDH1A1, and CD44). Mechanistically, Tanshinone IIA increased the level of lipid peroxides and decreased glutathione level in gastric cancer cells, both of which are the markers of ferroptosis. Similarly, ferroptosis inducers (erastin, sulfasalazine, and sorafenib) reduced gastric cancer cell stemness. Additionally, the inhibitory effects of Tanshinone IIA on GC cell stemness were reversed by ferroptosis inhibitor (Fer-1) or overexpression of SLC7A11, which is a critical ferroptosis inhibitor. Therefore, we revealed that Tanshinone IIA inhibited the stemness of gastric cancer cells partly through inducing ferroptosis.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  SLC7A11; Tanshinone IIA; ferroptosis; gastric cancer; stemness

Mesh:

Substances:

Year:  2021        PMID: 34661962     DOI: 10.1002/tox.23388

Source DB:  PubMed          Journal:  Environ Toxicol        ISSN: 1520-4081            Impact factor:   4.119


  5 in total

1.  Inhibition of cell survival and invasion by Tanshinone IIA via FTH1: A key therapeutic target and biomarker in head and neck squamous cell carcinoma.

Authors:  Wei Mao; Jian Ding; Yu Li; Ruofei Huang; Baoxin Wang
Journal:  Exp Ther Med       Date:  2022-06-16       Impact factor: 2.751

Review 2.  Ferroptosis and its Role in Gastric Cancer.

Authors:  Renjun Gu; Yawen Xia; Pengfei Li; Defang Zou; Keqin Lu; Lang Ren; Hongru Zhang; Zhiguang Sun
Journal:  Front Cell Dev Biol       Date:  2022-06-30

Review 3.  System Xc -/GSH/GPX4 axis: An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy.

Authors:  Feng-Jiao Li; Hui-Zhi Long; Zi-Wei Zhou; Hong-Yu Luo; Shuo-Guo Xu; Li-Chen Gao
Journal:  Front Pharmacol       Date:  2022-08-29       Impact factor: 5.988

4.  Role of TRPV1 ion channel in cervical squamous cell carcinoma genesis.

Authors:  Zhenming Wang; Junhong Dong; Wenxiu Tian; Sen Qiao; Hongmei Wang
Journal:  Front Mol Biosci       Date:  2022-08-22

5.  Combined Treatment of Tanshinone I and Epirubicin Revealed Enhanced Inhibition of Hepatocellular Carcinoma by Targeting PI3K/AKT/HIF-1α.

Authors:  Jiali Zhao; En Lin; Chaonong Cai; Manyao Zhang; Decheng Li; Shanglin Cai; Guifang Zeng; Zeren Yin; Bo Wang; Peiping Li; Xiaopeng Hong; Jiafan Chen; Baojia Zou; Jian Li
Journal:  Drug Des Devel Ther       Date:  2022-09-19       Impact factor: 4.319

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.